Pancreatic Cancer Market Trends

Growth Drivers

Rising Geriatric Population Across the World with Reduced Immunity – The chances of developing cancer cells in the body can increase with the age of the person. As per the estimations in 2023, more than 1 in 6 people in America which is 80 million people are now the age 65 and above.
Growing Number of Research Projects- The increasing number of financially funded research projects by the National Cancer Institute to develop medications and treatments is projected to propel the market’s growth.
Increasing Incidence of Cancers related to the Digestive System and Stomach owing to Unhealthy Foods –Consumption of red meat, processed meat, and meals are high in saturated fats, alcohol, and fructose-containing foods and drinks may raise the chance of developing pancreatic cancer.

Challenges

Side Effects of Radiation and Chemotherapy – The side effects of chemotherapy include pain, dizziness, fever, vomiting, and frequent bowel movement and the side effects of radiation therapy include diarrhea, shortness of breath, change in taste, and urinary and bladder problems. All these factors are estimated to be the reason for the hampering of market growth.

Rising Cost of Drug Development and Treatment
Stringent Government Regulatory Guidelines

Pancreatic Cancer Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	~ 18 %
Base Year Market Size (2023)	~ USD 6 Billion
Forecast Year Market Size (2036)	~ USD 36 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

The major factors driving the market growth are the increasing geriatric population around the world and the rising prevalence of obesity.

The market size of pancreatic cancer treatment is anticipated to attain a CAGR of 18% over the forecast period, i.e., 2023-2036.

Lack of skilled professionals and side effects of chemo and radiotherapy are estimated to be the growth hindering factors for the market expansion

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

The major players in the market are Amgen Inc., F. Hoffman-La Roche AG, Novartis AG, Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., Threshold Pharmaceuticals Inc., NewLink Genetics Corp, Infinity Pharmaceuticals Inc., Celgene Corporation.

Pancreatic Cancer Market Trends